Sagility Ltd.
NSE: SAGILITYSagility Ltd.: A 30-second snapshot
SAGILITY is an IT-sector stock listed on NSE, currently priced at ₹43.66 — below its 200-DMA of ₹46.06 and 24.5% off its 52-week high. Five-year revenue growth of 35.7% sits alongside a debt-to-equity ratio of 13.85, which is well above IT-sector norms, and a consistency score of 22/100 with no recorded ROE above 15%.
P/E
24.1
Forward P/E
18.1
ROE
—
Debt / Equity
13.85
Profit Margin
+12.6%
Div. Yield
+0.2%
5Y ROE > 15%
0/5
5Y FCF > 0
3/5
Quality
45/100
Recent context
- ·No news articles were captured in this analysis cycle — no recent headlines, corporate actions, or sector developments are available to assess.
- ·The debt trend is recorded as falling, which, if sustained, would reduce the D/E ratio from its current 13.85 level over time.
- ·SAGILITY ranks highest on quality score (tied at 62 with INFY) within the 6-peer IT group, despite the leverage concern — driven by the quality-score methodology, which may not fully weight debt structure.
Strengths
- +Five-year revenue CAGR of 35.7% and earnings CAGR of 23.9% indicate sustained top- and bottom-line expansion over the medium term.
- +FCF was positive in 3 of the available years, and the debt trend is classified as falling — suggesting incremental improvement in the balance sheet trajectory.
- +Profit margin of 12.61% is in positive territory for a business at this growth stage.
- +Forward PE of 18.09 represents a compression from the trailing PE of 24.12, implying earnings-growth expectations are being priced in.
Weaknesses
- −Debt-to-equity of 13.85 is an outlier relative to IT peers — HCLTECH, INFY, TCS, TECHM, and WIPRO all carry materially lower leverage — and represents a solvency-level risk flag for a services business.
- −ROE data is unavailable and zero years of ROE above 15% are recorded; the consistency score of 22/100 ranks last among the 6 IT peers tracked (quality rank 1 of 6, where 1 is lowest-ranked).
- −Price has been below the 200-DMA for a sustained period, with a 52-week drawdown of 24.5% and a 3-month decline of 9.5%, despite a 7.5% gain over the full year.
- −No analyst consensus rating is available, limiting the ability to triangulate fundamental views against the quantitative data.
Open questions
- ?Does the 13.85 debt-to-equity ratio reflect acquisition financing or operational leverage, and what is the repayment schedule relative to operating cash flows?
- ?How does SAGILITY's revenue growth of 35.7% over 5 years compare to the specific healthcare IT sub-segment it operates in, and is the growth rate decelerating?
- ?Given that ROE history is absent, what capital structure changes would be needed before return-on-equity metrics become meaningful benchmarks for this business?
- ?How does the forward PE compression from 24.1 to 18.1 relate to consensus earnings estimates, and what assumptions underpin those projections?
Peer comparison: IT
Ranks 1 of 6 on qualityTechnical state
Current price
₹43.66
SMA 50
₹40.96
SMA 200
₹46.06
RSI (14)
57.4 (neutral)
From 52w high
-24.5%
1Y return
+7.5%
3M return
-9.5%
50-DMA
Above
200-DMA
Below
Algorithmic support levels
Algorithmic resistance levels
Risk flags
- highDebt-to-equity of 13.85 is exceptionally elevated for an IT/services business; sector median is well below 1.0, placing SAGILITY far outside the peer leverage range.
- highROE is not available and consistency score is 22 out of 100, with 0 years of ROE above 15% recorded — indicating no demonstrated return on equity to date.
- mediumPrice trades 5.6% below the 200-DMA (₹46.06 vs ₹43.66 current) while the 52-week drawdown stands at -24.5%, suggesting sustained selling pressure over the medium term.
- mediumAnalyst consensus rating is unavailable (count = 10 analysts, no mean rating returned), limiting visibility into sell-side sentiment.
- lowNews section returned 0 articles — no recent coverage available to assess narrative risk or catalysts.
Cross-section contradictions
- 5-year revenue growth of 35.7% and 5-year earnings growth of 23.9% contrast with a consistency score of 22/100 and zero years of ROE above 15%, suggesting growth has not yet translated into capital efficiency.
- Price is 7.5% higher year-over-year yet sits 24.5% below the 52-week high and below the 200-DMA, indicating the annual gain masks a significant drawdown from the peak reached earlier in the period.
For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.
Fundamentals & technicals: refreshed 25 Jun 2026 · refreshed daily at 01:00 IST
AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 12 May 2026 · rotates through NIFTY 500 every ~5 days